Meag Munich Ergo’s Organon & Co OGN Stock Holding History

Meag Munich Ergo’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-662	Closed	-$20K	–	219
2021 Q4	$20K	Hold	662	–	–	﹤0.01%	197
2021 Q3	$22K	Buy	+662	New	+$21.2K	﹤0.01%	210

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Meag Munich Ergo's OGN Position: Q1 2022 in Review

Meag Munich Ergo sold out of Organon & Co (OGN) in Q1 2022, closing a stake of 662 shares — an estimated $20K sold.

Meag Munich Ergo first reported a position in OGN in Q3 2021 and held it in 2 quarters. The position peaked at $22K in Q3 2021. 818 funds tracked by Wall St. Rank hold OGN as of Q1 2022.

Meag Munich Ergo reported no remaining Organon & Co position as of Q1 2022 after selling out during the quarter.
Meag Munich Ergo sold 662 Organon & Co shares in Q1 2022, an estimated $20K.
Meag Munich Ergo first reported a position in Organon & Co in Q3 2021 and held it in 2 quarters.
Meag Munich Ergo's Organon & Co position peaked at $22K in Q3 2021.
818 funds tracked by Wall St. Rank held Organon & Co as of Q1 2022.

Based on Meag Munich Ergo's 13F filing for Q1 2022, filed 13 Apr 2022.